Volume 44, Issue 1

Search all Amino Acids articles

January 2013

Transglutaminases: future perspectives

Issue Editors:

S. Beninati,
F. Facchiano,
M. Piacentini

31 articles in this issue

Transglutaminases: future perspectives
S. Beninati
F. Facchiano
M. Piacentini
Minireview Article 30 November 2012 Pages: 1 - 9
In memoriam: John E. Folk (1925–2010)
Simone Beninati
Myung Hee Park
Mauro Piacentini
Obituary 31 July 2012 Pages: 11 - 18
Transglutaminases and receptor tyrosine kinases
Manaswini Sivaramakrishnan
Gary K. Shooter
Tristan I. Croll
Review Article 11 October 2011 Pages: 19 - 24
Transglutaminases: key regulators of cancer metastasis
Alessandro Lentini
Alberto Abbruzzese
Simone Beninati
Invited Review 01 February 2012 Pages: 25 - 32
Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer
V. M. Phatak
S. M. Croft
E. A. M. Verderio
Original Article 17 November 2011 Pages: 33 - 44
γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins
P. Torricelli
M. Caraglia
S. Beninati
Original Article 30 March 2012 Pages: 45 - 51
Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study
Francesco Facchiano
Daniela D’Arcangelo
Simone Beninati
Original Article 11 July 2012 Pages: 53 - 61
Tissue transglutaminase: a new target to reverse cancer drug resistance
Alfredo Budillon
Carmine Carbone
Elena Di Gennaro
Invited Review Open access 01 December 2011 Pages: 63 - 72
Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival
Se-Jin Kim
Kyung-Hee Kim
Soo-Youl Kim
Original Article 30 September 2011 Pages: 73 - 80
Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?
Santosh Kumar
Kapil Mehta
Invited Review 15 November 2011 Pages: 81 - 88
The role of TG2 in ECV304-related vasculogenic mimicry
Richard A. Jones
Zhuo Wang
Martin Griffin
Original Article 10 January 2012 Pages: 89 - 101
eIF5A isoforms and cancer: two brothers for two functions?
M. Caraglia
M. H. Park
A. Abbruzzese
Invited Review 03 December 2011 Pages: 103 - 109
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases
Antonio Martin
Alessandro Giuliano
Vittorio Gentile
Review Article 22 September 2011 Pages: 111 - 118
Recent advances in the development of tissue transglutaminase (TG2) inhibitors
E. Badarau
R. J. Collighan
M. Griffin
Invited Review 13 December 2011 Pages: 119 - 127
γ-Glutamylamines and neurodegenerative diseases
Thomas M. Jeitner
Kevin Battaile
Arthur J. L. Cooper
Invited Review 10 March 2012 Pages: 129 - 142
Probing the specificity of gamma-glutamylamine cyclotransferase: an enzyme involved in the metabolism of transglutaminase-catalyzed protein crosslinks
Todd E. Bowser
Mary Lynn Trawick
Original Article 27 November 2011 Pages: 143 - 150
Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress
Daniela Caccamo
Salvatore Condello
Riccardo Ientile
Original Article 21 September 2011 Pages: 151 - 159
Transglutaminase 6: a protein associated with central nervous system development and motor function
Helen Thomas
Konrad Beck
Daniel Aeschlimann
Original Article Open access 08 October 2011 Pages: 161 - 177
Tissue-specific responses to loss of transglutaminase 2
Stephanie Deasey
Shobana Shanmugasundaram
Maria Nurminskaya
Original Article 23 December 2011 Pages: 179 - 187
Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice
Hyun Yoo
Eu-Ree Ahn
Soo-Youl Kim
Original Article 10 October 2012 Pages: 189 - 197
Transglutaminase 2 as a biomarker of osteoarthritis: an update
Umberto Tarantino
Amedeo Ferlosio
Augusto Orlandi
Invited Review 03 December 2011 Pages: 199 - 207
Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides
Kazuya Watanabe
Kanako Tsunoda
Kiyotaka Hitomi
Original Article 02 November 2011 Pages: 209 - 214
Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions
Róbert Király
Endre Barta
László Fésüs
Original Article 13 December 2011 Pages: 215 - 225
The side chain of glutamine 13 is the acyl-donor amino acid modified by type 2 transglutaminase in subunit T of the native rabbit skeletal muscle troponin complex
Monica Squerzanti
Carlo Cervellati
Carla Esposito
Original Article 16 November 2011 Pages: 227 - 234
Retinoids produced by macrophages engulfing apoptotic cells contribute to the appearance of transglutaminase 2 in apoptotic thymocytes
Éva Garabuczi
Beáta Kiss
Zsuzsa Szondy
Original Article 14 October 2011 Pages: 235 - 244
Identification of human salivary transglutaminases
Mileidys Perez Alea
Vincent Thomas
Saïd El Alaoui
Original Article 12 November 2011 Pages: 245 - 250
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca²⁺ homeostasis
Ivana Caputo
Marilena Lepretti
Carla Esposito
Original Article 22 October 2011 Pages: 251 - 260
Nitric oxide regulates tissue transglutaminase localization and function in the vasculature
Simran K. Jandu
Alanah K. Webb
Lakshmi Santhanam
Original Article 08 October 2011 Pages: 261 - 269
Expression of different forms of transglutaminases by immature cells of Helianthus tuberosus sprout apices
Simone Beninati
Rosa Anna Iorio
Stefano Del Duca
Original Article 18 October 2012 Pages: 271 - 283
Transglutaminase-mediated modification of ovomucoid: effects on its trypsin inhibitory activity and antigenic properties
Raffaele Porta
Concetta Valeria L. Giosafatto
Loredana Mariniello
Original Article 22 November 2011 Pages: 285 - 292
Aloin enhances cisplatin antineoplastic activity in B16-F10 melanoma cells by transglutaminase-induced differentiation
Claudio Tabolacci
Stefania Rossi
Simone Beninati
Original Article 03 December 2011 Pages: 293 - 300

Volume 44, Issue 1

Transglutaminases: future perspectives

In memoriam: John E. Folk (1925–2010)

Transglutaminases and receptor tyrosine kinases

Transglutaminases: key regulators of cancer metastasis

Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer

γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins

Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study

Tissue transglutaminase: a new target to reverse cancer drug resistance

Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival

Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?

The role of TG2 in ECV304-related vasculogenic mimicry

eIF5A isoforms and cancer: two brothers for two functions?

Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases

Recent advances in the development of tissue transglutaminase (TG2) inhibitors

γ-Glutamylamines and neurodegenerative diseases

Probing the specificity of gamma-glutamylamine cyclotransferase: an enzyme involved in the metabolism of transglutaminase-catalyzed protein crosslinks

Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress

Transglutaminase 6: a protein associated with central nervous system development and motor function

Tissue-specific responses to loss of transglutaminase 2

Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice

Transglutaminase 2 as a biomarker of osteoarthritis: an update

Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides

Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions

The side chain of glutamine 13 is the acyl-donor amino acid modified by type 2 transglutaminase in subunit T of the native rabbit skeletal muscle troponin complex

Retinoids produced by macrophages engulfing apoptotic cells contribute to the appearance of transglutaminase 2 in apoptotic thymocytes

Identification of human salivary transglutaminases

Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca²⁺ homeostasis

Nitric oxide regulates tissue transglutaminase localization and function in the vasculature

Expression of different forms of transglutaminases by immature cells of Helianthus tuberosus sprout apices

Transglutaminase-mediated modification of ovomucoid: effects on its trypsin inhibitory activity and antigenic properties

Aloin enhances cisplatin antineoplastic activity in B16-F10 melanoma cells by transglutaminase-induced differentiation

Navigation